Profile | GDS4284 / 226928_x_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1075.01 | 75 |
GSM687648 | Patient 402 control | 1584.81 | 80 |
GSM687653 | Patient 403 control | 562.034 | 66 |
GSM687658 | Patient 404 control | 1085.41 | 75 |
GSM687663 | Patient 411 control | 1185.08 | 76 |
GSM687668 | Patient 422 control | 1417.41 | 79 |
GSM687673 | Patient 424 control | 1433.65 | 79 |
GSM687678 | Patient 425 control | 1395.64 | 78 |
GSM687683 | Patient 427 control | 1456.67 | 79 |
GSM687688 | Patient 428 control | 925.957 | 73 |
GSM687695 | Patient 441 control | 4042.98 | 92 |
GSM687699 | Patient 443 control | 1582.15 | 81 |
GSM687704 | Patient 444 control | 889.94 | 72 |
GSM687707 | Patient 448 control | 2109.03 | 85 |
GSM687712 | Patient 449 control | 1220.04 | 77 |
GSM687719 | Patient 450 control | 1975.01 | 84 |
GSM687724 | Patient 451 control | 4649.64 | 93 |
GSM687728 | Patient 452 control | 1722.67 | 82 |
GSM687646 | Patient 401 treated 24h | 550.835 | 64 |
GSM687649 | Patient 402 treated 24h | 1757.5 | 82 |
GSM687665 | Patient 411 treated 24h | 717.337 | 69 |
GSM687651 | Patient 402 treated 4 weeks | 2160.54 | 85 |
GSM687667 | Patient 411 treated 4 weeks | 879.341 | 72 |
GSM687670 | Patient 422 treated 24h | 1010.75 | 74 |
GSM687671 | Patient 422 treated 4 weeks | 1046.6 | 74 |
GSM687654 | Patient 403 treated 24h | 696.346 | 69 |
GSM687675 | Patient 424 treated 24h | 1858.76 | 83 |
GSM687685 | Patient 427 treated 24h | 1426.07 | 79 |
GSM687656 | Patient 403 treated 4 weeks | 556.082 | 66 |
GSM687677 | Patient 424 treated 4 weeks | 662.503 | 67 |
GSM687687 | Patient 427 treated 4 weeks | 606.882 | 66 |
GSM687692 | Patient 428 treated 4h | 1353.65 | 78 |
GSM687716 | Patient 449 treated 4h | 696.371 | 69 |
GSM687722 | Patient 450 treated 4h | 1803.93 | 83 |
GSM687680 | Patient 425 treated 24h | 1109.36 | 75 |
GSM687690 | Patient 428 treated 24h | 1708.42 | 82 |
GSM687700 | Patient 443 treated 24h | 1694.58 | 82 |
GSM687705 | Patient 444 treated 24h | 1407.6 | 79 |
GSM687714 | Patient 449 treated 24h | 1452.55 | 80 |
GSM687721 | Patient 450 treated 24h | 3883.93 | 92 |
GSM687682 | Patient 425 treated 4 weeks | 914.961 | 73 |
GSM687694 | Patient 428 treated 4 weeks | 802.022 | 70 |
GSM687702 | Patient 443 treated 4 weeks | 1288.25 | 77 |
GSM687718 | Patient 449 treated 4 weeks | 713.333 | 69 |
GSM687723 | Patient 450 treated 4 weeks | 2571.99 | 87 |
GSM687661 | Patient 404 treated 4h | 1824.17 | 83 |
GSM687710 | Patient 448 treated 4h | 3237.31 | 89 |
GSM687726 | Patient 451 treated 4h | 2100.2 | 85 |
GSM687730 | Patient 452 treated 4h | 1765.49 | 84 |
GSM687660 | Patient 404 treated 24h | 14980.9 | 98 |
GSM687697 | Patient 441 treated 24h | 2781.28 | 88 |
GSM687709 | Patient 448 treated 24h | 2235.69 | 85 |
GSM687725 | Patient 451 treated 24h | 2528.96 | 87 |
GSM687729 | Patient 452 treated 24h | 2757.7 | 89 |
GSM687727 | Patient 451 treated 4 weeks | 2099.79 | 85 |
GSM687731 | Patient 452 treated 4 weeks | 1619.69 | 81 |